METOCLOPRAMIDE-INDUCED PARKINSONISM - CLINICAL CHARACTERISTICS OF 10 CASES

被引:76
作者
INDO, T [1 ]
ANDO, K [1 ]
机构
[1] NATL CTR NERVOUS MENTAL & MUSCULAR DISORDERS,TOKYO,JAPAN
关键词
D O I
10.1001/archneur.1982.00510200036006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:494 / 496
页数:3
相关论文
共 8 条
[1]  
AHTEE L, 1974, ACTA PHARMACOL TOX, V35, P429
[2]  
Borenstein P, 1965, Therapie, V20, P975
[3]   TARDIVE-DYSKINESIA ASSOCIATED WITH METOCLOPRAMIDE [J].
LAVY, S ;
MELAMED, E ;
PENCHAS, S .
BRITISH MEDICAL JOURNAL, 1978, 1 (6105) :77-78
[4]  
Marsden C D, 1975, Adv Neurol, V9, P165
[5]  
MENON G N, 1965, Indian Med J, V59, P21
[6]  
ROBINSON OP, 1973, POSTGRAD MED J, V49, P77
[7]  
STRANG RR, 1966, CAN MED ASSOC J, V95, P928
[8]   METOCLOPRAMIDE AND PIMOZIDE IN PARKINSONS-DISEASE AND LEVODOPA-INDUCED DYSKINESIAS [J].
TARSY, D ;
PARKES, JD ;
MARSDEN, CD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1975, 38 (04) :331-335